Development of nano-sized ketoprofen lysine incorporated Eudragit® S100 nanomedicine by double emulsion solvent evaporation and in vitro characterization

Creative Commons License

Öztürk A. A., Çinar N. İ., Yenilmez E.

Journal of Pharmacy and Pharmacognosy Research, cilt.7, sa.1, ss.47-58, 2019 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 1
  • Basım Tarihi: 2019
  • Dergi Adı: Journal of Pharmacy and Pharmacognosy Research
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.47-58
  • Anahtar Kelimeler: Eudragit® S100, Ketoprofen lysine, Nanoparticle
  • Anadolu Üniversitesi Adresli: Evet

Özet

Context: Pain has a very important effect on the biological, psychological, sociological and economic situation of a patient. Nanoparticles (NPs) are being extensively investigated as drug delivery systems worldwide for pharmaceutical applications.

Aims: To design and compare the release characteristics of sustained-release formulations of ketoprofen lysine (KL) NPs.

Methods: KL-Eudragit® S100 NPs were produced by double emulsion solvent evaporation method. The physicochemical characteristics of NPs were studied.

Results: Particle size of NPs prepared was in the range of 99 and 141 nm. Encapsulation efficiency (%) was obtained (76%) for NP formulations prepared. Weibull models were determined to be the most appropriate kinetic models for NP containing KL. KL-loaded NPs demonstrated nanostructural character and NPs showed extended release of KL.

Conclusions: NPs developed were found to be stable and representing a promising system for sustained delivery of KL.